Premium
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription. Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription.
– Norbert Bischofberger, Ph.D., is stepping down from his role as President & CEO – – Deborah Knobelman, Ph.D., COO & CFO, is named President & Interim CEO – SAN MATEO, Calif. and...
– Preclinical data demonstrate the ability of p300 KAT inhibition to modulate multiple pro-inflammatory signaling pathways, including antibodies and cytokine production, in ex vivo and in vivo...
– Discontinuing development of istisociclib, a CDK9 inhibitor; benefit-risk profile in platinum-resistant high-grade serous ovarian cancer does not support further development – – Kronos Bio...
– Data demonstrates Kronos Bio's approach to targeting oncogenic transcription factors and the strong relationship between IRF4 and p300 in Multiple Myeloma – – Poster presentation to take place...
SAN MATEO, Calif., and CAMBRIDGE, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to developing small molecule therapeutics that address cancers and...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.09 | 9.89010989011 | 0.91 | 0.997 | 0.8902 | 451942 | 0.94506477 | CS |
| 4 | -0.01 | -0.990099009901 | 1.01 | 1.09 | 0.8902 | 342113 | 0.95736662 | CS |
| 12 | 0.02 | 2.04081632653 | 0.98 | 1.09 | 0.8 | 261503 | 0.93551598 | CS |
| 26 | -0.18 | -15.2542372881 | 1.18 | 1.6 | 0.8 | 183614 | 1.01486871 | CS |
| 52 | -0.15 | -13.0434782609 | 1.15 | 1.6 | 0.69 | 282434 | 1.04060424 | CS |
| 156 | -12.62 | -92.657856094 | 13.62 | 14.57 | 0.69 | 296105 | 2.57641321 | CS |
| 260 | -27.29 | -96.4651820431 | 28.29 | 39.605 | 0.69 | 281867 | 8.14026862 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
